BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

366 related articles for article (PubMed ID: 23229280)

  • 1. Role of KCNJ5 in familial and sporadic primary aldosteronism.
    Mulatero P; Monticone S; Rainey WE; Veglio F; Williams TA
    Nat Rev Endocrinol; 2013 Feb; 9(2):104-12. PubMed ID: 23229280
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Somatic ATP1A1, ATP2B3, and KCNJ5 mutations in aldosterone-producing adenomas.
    Williams TA; Monticone S; Schack VR; Stindl J; Burrello J; Buffolo F; Annaratone L; Castellano I; Beuschlein F; Reincke M; Lucatello B; Ronconi V; Fallo F; Bernini G; Maccario M; Giacchetti G; Veglio F; Warth R; Vilsen B; Mulatero P
    Hypertension; 2014 Jan; 63(1):188-95. PubMed ID: 24082052
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New insights into aldosterone-producing adenomas and hereditary aldosteronism: mutations in the K+ channel KCNJ5.
    Scholl UI; Lifton RP
    Curr Opin Nephrol Hypertens; 2013 Mar; 22(2):141-7. PubMed ID: 23318698
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role for germline mutations and a rare coding single nucleotide polymorphism within the KCNJ5 potassium channel in a large cohort of sporadic cases of primary aldosteronism.
    Murthy M; Xu S; Massimo G; Wolley M; Gordon RD; Stowasser M; O'Shaughnessy KM
    Hypertension; 2014 Apr; 63(4):783-9. PubMed ID: 24420545
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A revised mechanism of action of hyperaldosteronism-linked mutations in cytosolic domains of GIRK4 (KCNJ5).
    Shalomov B; Handklo-Jamal R; Reddy HP; Theodor N; Bera AK; Dascal N
    J Physiol; 2022 Mar; 600(6):1419-1437. PubMed ID: 34957562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. a Novel Y152C KCNJ5 mutation responsible for familial hyperaldosteronism type III.
    Monticone S; Hattangady NG; Penton D; Isales CM; Edwards MA; Williams TA; Sterner C; Warth R; Mulatero P; Rainey WE
    J Clin Endocrinol Metab; 2013 Nov; 98(11):E1861-5. PubMed ID: 24037882
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel KCNJ5-insT149 somatic mutation close to, but outside, the selectivity filter causes resistant hypertension by loss of selectivity for potassium.
    Kuppusamy M; Caroccia B; Stindl J; Bandulik S; Lenzini L; Gioco F; Fishman V; Zanotti G; Gomez-Sanchez C; Bader M; Warth R; Rossi GP
    J Clin Endocrinol Metab; 2014 Sep; 99(9):E1765-73. PubMed ID: 25057880
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Primary aldosteronism: new insights into familial forms].
    van den Meiracker AH; van der Linde AA; Claahsen van der Grinten HL; Danser AH; Deinum J
    Ned Tijdschr Geneeskd; 2015; 159():A8932. PubMed ID: 26420144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. KCNJ5 mutations in European families with nonglucocorticoid remediable familial hyperaldosteronism.
    Mulatero P; Tauber P; Zennaro MC; Monticone S; Lang K; Beuschlein F; Fischer E; Tizzani D; Pallauf A; Viola A; Amar L; Williams TA; Strom TM; Graf E; Bandulik S; Penton D; Plouin PF; Warth R; Allolio B; Jeunemaitre X; Veglio F; Reincke M
    Hypertension; 2012 Feb; 59(2):235-40. PubMed ID: 22203740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic causes of primary aldosteronism.
    Seidel E; Schewe J; Scholl UI
    Exp Mol Med; 2019 Nov; 51(11):1-12. PubMed ID: 31695023
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Minireview: potassium channels and aldosterone dysregulation: is primary aldosteronism a potassium channelopathy?
    Gomez-Sanchez CE; Oki K
    Endocrinology; 2014 Jan; 155(1):47-55. PubMed ID: 24248457
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potassium channel mutant KCNJ5 T158A expression in HAC-15 cells increases aldosterone synthesis.
    Oki K; Plonczynski MW; Luis Lam M; Gomez-Sanchez EP; Gomez-Sanchez CE
    Endocrinology; 2012 Apr; 153(4):1774-82. PubMed ID: 22315453
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary aldosteronism and potassium channel mutations.
    Stowasser M
    Curr Opin Endocrinol Diabetes Obes; 2013 Jun; 20(3):170-9. PubMed ID: 23426162
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative Genomics and Transcriptome Profiling in Primary Aldosteronism.
    Aristizabal Prada ET; Castellano I; Sušnik E; Yang Y; Meyer LS; Tetti M; Beuschlein F; Reincke M; Williams TA
    Int J Mol Sci; 2018 Apr; 19(4):. PubMed ID: 29642543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. K+ channel mutations in adrenal aldosterone-producing adenomas and hereditary hypertension.
    Choi M; Scholl UI; Yue P; Björklund P; Zhao B; Nelson-Williams C; Ji W; Cho Y; Patel A; Men CJ; Lolis E; Wisgerhof MV; Geller DS; Mane S; Hellman P; Westin G; Åkerström G; Wang W; Carling T; Lifton RP
    Science; 2011 Feb; 331(6018):768-72. PubMed ID: 21311022
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutated KCNJ5 activates the acute and chronic regulatory steps in aldosterone production.
    Hattangady NG; Karashima S; Yuan L; Ponce-Balbuena D; Jalife J; Gomez-Sanchez CE; Auchus RJ; Rainey WE; Else T
    J Mol Endocrinol; 2016 Jul; 57(1):1-11. PubMed ID: 27099398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Familial hyperaldosteronism type III a novel case and review of literature.
    Pons Fernández N; Moreno F; Morata J; Moriano A; León S; De Mingo C; Zuñiga Á; Calvo F
    Rev Endocr Metab Disord; 2019 Mar; 20(1):27-36. PubMed ID: 30569443
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel point mutation in the KCNJ5 gene causing primary hyperaldosteronism and early-onset autosomal dominant hypertension.
    Charmandari E; Sertedaki A; Kino T; Merakou C; Hoffman DA; Hatch MM; Hurt DE; Lin L; Xekouki P; Stratakis CA; Chrousos GP
    J Clin Endocrinol Metab; 2012 Aug; 97(8):E1532-9. PubMed ID: 22628607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence, clinical, and molecular correlates of KCNJ5 mutations in primary aldosteronism.
    Boulkroun S; Beuschlein F; Rossi GP; Golib-Dzib JF; Fischer E; Amar L; Mulatero P; Samson-Couterie B; Hahner S; Quinkler M; Fallo F; Letizia C; Allolio B; Ceolotto G; Cicala MV; Lang K; Lefebvre H; Lenzini L; Maniero C; Monticone S; Perrocheau M; Pilon C; Plouin PF; Rayes N; Seccia TM; Veglio F; Williams TA; Zinnamosca L; Mantero F; Benecke A; Jeunemaitre X; Reincke M; Zennaro MC
    Hypertension; 2012 Mar; 59(3):592-8. PubMed ID: 22275527
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary Aldosteronism: KCNJ5 Mutations and Adrenocortical Cell Growth.
    Yang Y; Gomez-Sanchez CE; Jaquin D; Aristizabal Prada ET; Meyer LS; Knösel T; Schneider H; Beuschlein F; Reincke M; Williams TA
    Hypertension; 2019 Oct; 74(4):809-816. PubMed ID: 31446799
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.